- Market Capitalization, $K 155,275,520
- Shares Outstanding, K 2,354,800
- Annual Sales, $ 18,291 M
- Annual Income, $ 5,839 M
- 60-Month Beta 0.46
- Price/Sales 8.36
- Price/Cash Flow 23.00
- Price/Book 19.04
|Period||Period Low||Period High||Performance|
| || |
+2.90 (+4.60%)since 04/29/20
| || |
+7.81 (+13.44%)since 02/28/20
| || |
+18.91 (+40.21%)since 05/29/19
Top Stock Reports for Novo Nordisk, IBM & Honeywell
On Tuesday, May 26, President Donald Trump announced a breakthrough program to cap the out of pocket cost of insulin to senior citizens on Medicare. The Trump administration is partnering with leaders...
, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for OSTK, NVO, CHGG, TSLA, and NFLX.
Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809) today announced the financial results and corporate updates for the first quarter 2020.
Bagsvaerd, Denmark, 13 May 2020 - Novo Nordisk today announced headline results from STEP 4, the first completed phase 3a trial in the STEP programme. STEP 4 is a randomised, double-blind, multicentre,...
Reportlinker.com announces the release of the report "Global Smart Insulin Pen Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025" -...
Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon(TM) technologies to address unmet medical needs, today announced that the company will appoint Jesper...
The "Anti-Diabetic Drugs Market - Forecasts from 2020 to 2025" report has been added to ResearchAndMarkets.com's offering.
Novo Nordisk (NVO) and Bristol-Myers (BMY) announce Q1 results. Pfizer (PFE), Roche (RHHBY) and Lilly (LLY) provide update on their coronavirus-related research efforts.